ArticleFrontiers in immunology2021

Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCT.

Fanny Luterbacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.